Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mao-Chi Weng"'
Autor:
Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, Yu-Chang Liu, Wu Jeng-Yuan, Fei-Ting Hsu, Hsin-Ell Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 118, Iss , Pp - (2019)
Externí odkaz:
https://doaj.org/article/8a691784275c43f29545d1125797f546
Autor:
Mao-Chi Weng, Ming-Hsin Li, Jing Gung Chung, Yu-Chang Liu, Jeng-Yuan Wu, Fei-Ting Hsu, Hsin-Ell Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 116, Iss , Pp 109032- (2019)
Non-small cell lung cancer (NSCLC) is a malignant lung cancer type with poor prognosis. NF-κB, the oncogenic transcription factor, has been recognized as an important mediator in progression of NSCLC. Regorafenib, a multikinase inhibitor, was demons
Externí odkaz:
https://doaj.org/article/c5acb676caa64977be4cd77b01277771
Autor:
Mao-Chi Weng, 翁茂琦
97
Objectives: This study evaluated the gene-mediated tumor imaging and therapy of a hepatocellular carcinoma-bearing mouse model. The mouse bearing both anti-PEG receptor-expressed tumor (HCC36/AGP3-LDLR, HLDL) and wild-type tumor (HCC36) was i
Objectives: This study evaluated the gene-mediated tumor imaging and therapy of a hepatocellular carcinoma-bearing mouse model. The mouse bearing both anti-PEG receptor-expressed tumor (HCC36/AGP3-LDLR, HLDL) and wild-type tumor (HCC36) was i
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/yx53a3
Autor:
Fei-Ting Hsu, Bo-Siang Fu, Ching-Hsuan Wu, Mao-Chi Weng, Jai-Jen Tsai, Po-Jung Pan, Kung-Hung Lin
Publikováno v:
Anticancer Research. 41:1251-1259
Background/aim Sorafenib, an oral multi-kinase inhibitor, has been shown to improve the outcome of patients with osteosarcoma (OS). However, the anti-OS effect and mechanism of sorafenib has not yet been fully understood. The main purpose of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e03a90d14e6ea1e478f159274ee0a7
https://doi.org/10.21873/anticanres.14882
https://doi.org/10.21873/anticanres.14882
Autor:
Jeng-Yuan Wu, Mao-Chi Weng, Yu-Chang Liu, Song Shei Lin, Chien-Yi Ting, Fei-Ting Hsu, Charles Chung-Wei Lin, Alexander Lan, Chia-Jung Tsai, Jing Gung Chung
Publikováno v:
Anticancer research. 41(6)
Background/aim Non-small cell lung cancer (NSCLC) is the most common type of lung cancer with poor prognosis. Lenvatinib is a multi-kinase inhibitor that has the potential to suppress tumor progression. Our previous study suggested that lenvatinib in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65e38a4b29bb2136e3a176596971f73f
https://pubmed.ncbi.nlm.nih.gov/34083277
https://pubmed.ncbi.nlm.nih.gov/34083277
Autor:
Chih-Hung Chiang, Yu-Chang Liu, Jing Gung Chung, I-Tsang Chiang, Fei-Ting Hsu, Song Shei Lin, Yuan-Hao Lee, Mao-Chi Weng, Jung-Hung Hsieh, Cheng-Shyong Chang
Publikováno v:
In Vivo
Background Although both chemotherapy and radiotherapy (RT) can sufficiently maintain tumor suppression of colorectal cancer (CRC), these treatments may trigger the expression of nuclear factor kappa B (NF-κB) and compromise patients' survival. Rego
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce02074a851f5d6449b1846be2bd022a
https://europepmc.org/articles/PMC7811665/
https://europepmc.org/articles/PMC7811665/
Publikováno v:
Polymers
Volume 12
Issue 6
Volume 12
Issue 6
pH responsive chitosan and 3-Glycidyloxypropyl trimethoxysilane (GPTMS) hydrogels were synthesized by the sol-gel crosslinking reaction. GPTMS was introduced to influence several behaviors of the chitosan hydrogels, such as the swelling ratio, mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e209263d34b6e1c7b197ef8fecf24231
http://europepmc.org/articles/PMC7362259
http://europepmc.org/articles/PMC7362259
Autor:
Bi-Jhih Chen, Mao-Chi Weng, Hwai-Jeng Lin, Yen-Chung Chen, Wei-Shu Wang, Chih-Wei Tseng, I-Tsang Chiang, Yu Cheng Kuo, Wei-Ting Chen
Publikováno v:
Anticancer Research. 37:161-168
The aim of the present study was to investigate the antitumor effect and mechanism of action of hyperforin in hepatocellular carcinoma (HCC) SK-Hep1 cells in vitro. Cells were treated with different concentrations of hyperforin for different periods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae53c5ff82359cb167bde583b95abd5
https://doi.org/10.21873/anticanres.11301
https://doi.org/10.21873/anticanres.11301
Autor:
Hsin Ell Wang, Fei-Ting Hsu, Mao Chi Weng, Yu Chang Liu, Ming Hsin Li, Jeng Yuan Wu, Jing Gung Chung
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 116, Iss, Pp 109032-(2019)
Non-small cell lung cancer (NSCLC) is a malignant lung cancer type with poor prognosis. NF-κB, the oncogenic transcription factor, has been recognized as an important mediator in progression of NSCLC. Regorafenib, a multikinase inhibitor, was demons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab9919527422b2603bb590347f36eea
https://doi.org/10.1016/j.biopha.2019.109032
https://doi.org/10.1016/j.biopha.2019.109032
Autor:
YU-CHANG LIU, I-TSANG CHIANG, JING-GUNG CHUNG, JUNG-HUNG HSIEH, CHIH-HUNG CHIANG, MAO-CHI WENG, FEI-TING HSU, YUAN-HAO LEE, CHENG-SHYONG CHANG, SONG-SHEI LIN
Publikováno v:
In Vivo; Nov/Dec2020, Vol. 34 Issue 6, p3217-3224, 8p